The recent coronavirus vaccine news

The pair will continue to move lower in the following days towards the 101.000 support line. The optimism of investors from the recent coronavirus vaccine news quickly fades away. This was amidst the continued rise of COVID-19 cases in the United States coupled with a spike in the number of unemployed individuals in the country. US pharmaceutical companies Pfizer and Moderna reported a high effectiveness rate on its Phase 3 trial. Once approved, the vaccines will be available commercially. However, if the trend in the cases continued in the near term, the daily production of the vaccine will not be sufficient for the number of new cases. The US has currently 12.3 million cases with its highest daily infection recorded on Friday, November 20, at 198,585. The rise in cases reflects in the surge in the number of individuals filing for their unemployment benefits. Last week’s figure was 742,000 compared to the prior week’s 711,000 results.